| Olmesartan/Hydrochlorothiazide Krka 40 mg/25 mg film-coated tablets PA1347/061/004 |
Olmesartan medoxomil, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Marketed |
| Olopatadine Misom 1 mg/mL eye drops, solution PA23148/011/001 |
Olopatadine hydrochloride |
Brown & Burk IR Limited |
Not marketed |
| Olumiant 1 mg film-coated tablets EU/1/16/1170/017-019 |
Baricitinib |
Eli Lilly Nederland B.V. |
— |
| Olumiant 2 mg film-coated tablets EU/1/16/1170/001-008 |
Baricitinib |
Eli Lilly Nederland B.V. |
— |
| Olumiant 4 mg film-coated tablets EU/1/16/1170/009-016 |
Baricitinib |
Eli Lilly Nederland B.V. |
— |
| Omacor 1000 mg Soft Capsules PA1099/001/001 |
Omega-3-acid ethyl esters |
BASF AS |
Marketed |
| Omacor 1000 mg Soft Capsules PPA0465/335/001 |
Omega-3-acid ethyl esters 90 |
PCO Manufacturing Ltd. |
— |
| Omacor 1000 mg Soft Capsules PPA1463/042/001 |
Omega-3-acid ethyl esters |
IMED Healthcare Ltd., |
— |
| Omeflex peri emulsion for infusion PA0736/033/002 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine |
B. Braun Melsungen AG |
Marketed |
| Omeflex plus emulsion for infusion PA0736/039/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine |
B. Braun Melsungen AG |
Marketed |
| Omeflex special emulsion for infusion PA0736/040/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine |
B. Braun Melsungen AG |
Marketed |
| Omeflex special without electrolytes emulsion for infusion PA0736/038/001 |
Isoleucine, Leucine, Lysine monohydrate, Methionine, Phenylalanine |
B. Braun Melsungen AG |
Marketed |
| Omeprazole 10 mg Gastro-resistant Capsules, hard PA23266/077/001 |
Omeprazole |
Viatris Limited |
Not marketed |
| Omeprazole 10 mg hard gastro-resistant capsules PA2315/129/001 |
Omeprazole |
Accord Healthcare Ireland Ltd. |
Marketed |
| Omeprazole 20 mg Gastro-resistant Capsules, hard PA23266/077/002 |
Omeprazole |
Viatris Limited |
Not marketed |
| Omeprazole 20 mg hard gastro-resistant capsules PA2315/129/002 |
Omeprazole |
Accord Healthcare Ireland Ltd. |
Marketed |
| Omeprazole 40 mg Gastro-resistant Capsules, hard PA23266/077/003 |
Omeprazole |
Viatris Limited |
Not marketed |
| Omeprazole 40 mg hard gastro-resistant capsules PA2315/129/003 |
Omeprazole |
Accord Healthcare Ireland Ltd. |
Marketed |
| Omeprazole Bluefish 10 mg gastro-resistant capsules PA1436/007/001 |
Omeprazole |
Bluefish Pharmaceuticals AB |
Marketed |
| Omeprazole Bluefish 20 mg gastro-resistant capsules PA1436/007/002 |
Omeprazole |
Bluefish Pharmaceuticals AB |
Marketed |
| Omeprazole Bluefish 40 mg gastro-resistant capsules PA1436/007/003 |
Omeprazole |
Bluefish Pharmaceuticals AB |
Marketed |
| Omeprazole Pinewood 20 mg gastro-resistant capsules, hard PA0281/152/001 |
Omeprazole |
Pinewood Laboratories Limited |
Not marketed |
| Omeprazole Rowa 20 mg Gastro-resistant Capsules, hard PA0074/075/002 |
Omeprazole |
Rowa Pharmaceuticals Limited, |
Marketed |
| Omeprazole Rowa 40 mg Gastro-Resistant Capsules, hard PA0074/075/003 |
Omeprazole |
Rowa Pharmaceuticals Limited, |
Marketed |
| Omeprazole Teva 10 mg gastro-resistant capsules, hard PA0749/160/001 |
Omeprazole |
Teva Pharma B.V. |
Marketed |
| Omeprazole Teva 20 mg gastro-resistant capsules, hard PA0749/160/002 |
Omeprazole |
Teva Pharma B.V. |
Marketed |
| Omeprazole Teva 40 mg Gastro-resistant Capsules, hard PA0749/160/003 |
Omeprazole |
Teva Pharma B.V. |
Marketed |
| Omesar 10 mg film-coated tablets PA0865/011/001 |
Olmesartan medoxomil |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Omesar 20 mg film-coated tablets PA0865/011/002 |
Olmesartan medoxomil |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Omesar 40 mg film-coated tablets PA0865/011/003 |
Olmesartan medoxomil |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Omesar Plus 20 mg/12.5 mg film-coated tablets PA0865/014/001 |
Olmesartan medoxomil, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Omesar Plus 20 mg/25 mg film-coated tablets PA0865/014/002 |
Olmesartan medoxomil, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Omesar Plus 40 mg/12.5 mg film-coated tablets PA0865/014/003 |
Olmesartan medoxomil, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Omesar Plus 40 mg/25 mg film-coated tablets PA0865/014/004 |
Olmesartan medoxomil, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Omidria 10 mg/ml + 3 mg/ml concentration for solution for intraocular irrigation EU/1/15/1018/001 |
Phenylephrine hydrochloride, Ketorolac trometamol |
Rayner Surgical (Ireland) Limited |
— |
| Omjjara 100 mg film-coated tablets EU/1/23/1782/001 |
Momelotinib Dihydrochloride Monohydrate |
GlaxoSmithKline Trading Services Limited |
— |
| Omjjara 150 mg film-coated tablets EU/1/23/1782/002 |
Momelotinib Dihydrochloride Monohydrate |
GlaxoSmithKline Trading Services Limited |
— |
| Omjjara 200 mg film-coated tablets EU/1/23/1782/003 |
Momelotinib Dihydrochloride Monohydrate |
GlaxoSmithKline Trading Services Limited |
— |
| Omlyclo 150 mg solution for injection in pre-filled syringe EU/1/24/1817/002-004 |
Omalizumab |
Celltrion Healthcare Hungary Kft. |
— |
| Omlyclo 75 mg solution for injection in pre-filled syringe EU/1/24/1817/001 |
Omalizumab |
Celltrion Healthcare Hungary Kft. |
— |
| Omnexel, 400 micrograms prolonged release tablets, film-coated PPA0465/171/001 |
Tamsulosin hydrochloride |
PCO Manufacturing Ltd. |
— |
| Omnexel®, 400 micrograms prolonged release tablets, film-coated PA1241/006/001 |
Tamsulosin hydrochloride |
Astellas Pharma Co. Limited |
Marketed |
| Omnexel®, 400 micrograms prolonged release tablets, film-coated PPA1463/025/001 |
Tamsulosin hydrochloride |
IMED Healthcare Ltd., |
— |
| Omnipaque 140 mg I/ml Solution for Injection (Glass) PA0735/006/001 |
Iohexol |
GE Healthcare AS |
Not marketed |
| Omnipaque 180 mg I/ml Solution for Injection (Glass) PA0735/006/002 |
Iohexol |
GE Healthcare AS |
Marketed |
| Omnipaque 240 mg I/ml Solution for Injection (Glass) PA0735/006/004 |
Iohexol |
GE Healthcare AS |
Marketed |
| Omnipaque 240 mg I/ml Solution for Injection (Polypropylene) PA0735/006/023 |
Iohexol |
GE Healthcare AS |
Marketed |
| Omnipaque 300 mg I/ml Solution for Injection (Glass) PA0735/006/008 |
Iohexol |
GE Healthcare AS |
Marketed |
| Omnipaque 300 mg I/ml Solution for Injection (Polypropylene) PA0735/006/018 |
Iohexol |
GE Healthcare AS |
Marketed |
| Omnipaque 350 mg I/ml Solution for Injection (Glass) PA0735/006/013 |
Iohexol |
GE Healthcare AS |
Not marketed |